• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情大流行时代过敏性和免疫性疾病患者的管理

Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.

作者信息

Patella Vincenzo, Delfino Gabriele, Florio Giovanni, Spadaro Giuseppe, Chieco Bianchi Fulvia, Senna Gianerico, Di Gioacchino Mario

机构信息

Division Allergy and Clinical Immunology, Department of Medicine, "Santa Maria Della Speranza" Hospital, Salerno, Italy.

Postgraduate Program in Allergy and Clinical Immunology, University of Naples Federico II, Naples, Italy.

出版信息

Clin Mol Allergy. 2020 Oct 1;18:18. doi: 10.1186/s12948-020-00134-5. eCollection 2020.

DOI:10.1186/s12948-020-00134-5
PMID:33020697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7528155/
Abstract

The pandemic COVID-19 abruptly exploded, taking most health professionals around the world unprepared. Italy, the first European country to be hit violently, was forced to activate the lockdown in mid-February 2020. At the time of the spread, a high number of victims were quickly registered, especially in the regions of Northern Italy which have a high rate of highly-polluting production activities. The need to hospitalize the large number of patients with severe forms of COVID-19 led the National Health System to move a large number of specialists from their disciplines to the emergency hospital departments for the treatment of COVID-19. Furthermore, the lockdown itself has limited the possibility for general practitioners and pediatricians to be able to make outpatient visits and/or home care for patients with chronic diseases. Among them, the patient with atopic diseases, such as asthma, rhinitis and atopic dermatitis, is worthy of particular attention as she/he is immersed in a studded negative scenario with the onset of spring, a factor that should not be underestimated for those who suffer from pollen allergy. The Italian Society of Asthma Allergology and Clinical Immunology, to quickly deal with the lack of references and specialist medical procedures, has produced a series of indications for immunologic patient care that are reported in this paper, and can be used as guidelines by specialists of our discipline.

摘要

新冠疫情突然爆发,让全球大多数医疗专业人员措手不及。意大利是首个遭受重创的欧洲国家,于2020年2月中旬被迫实施封锁。在疫情传播期间,迅速登记了大量受害者,尤其是在意大利北部地区,那里高污染生产活动的比例很高。大量新冠重症患者需要住院治疗,这使得国家卫生系统将大量专科医生从各自的专业领域调至急诊科室来治疗新冠患者。此外,封锁本身限制了全科医生和儿科医生对慢性病患者进行门诊和/或上门护理的可能性。其中,患有特应性疾病(如哮喘、鼻炎和特应性皮炎)的患者值得特别关注,因为随着春天的到来,他们置身于一连串不利的情况中,对于花粉过敏患者而言,这一因素不容小觑。意大利哮喘过敏与临床免疫学会为迅速应对参考资料和专业医疗程序的匮乏,制定了一系列免疫患者护理指南,本文予以报道,可供本学科专家用作指导方针。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c43/7532082/cb2d85f637b8/12948_2020_134_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c43/7532082/cb2d85f637b8/12948_2020_134_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c43/7532082/cb2d85f637b8/12948_2020_134_Fig1_HTML.jpg

相似文献

1
Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era.新冠疫情大流行时代过敏性和免疫性疾病患者的管理
Clin Mol Allergy. 2020 Oct 1;18:18. doi: 10.1186/s12948-020-00134-5. eCollection 2020.
2
Pediatric allergy and immunology in Italy.意大利儿科过敏与免疫学
Pediatr Allergy Immunol. 2011 May;22(3):267-76. doi: 10.1111/j.1399-3038.2011.01157.x.
3
Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity.花粉诱发的过敏性鼻炎在 1360 名意大利儿童中的表现:共病和严重程度的决定因素。
Pediatr Allergy Immunol. 2013 Dec;24(8):742-51. doi: 10.1111/pai.12136. Epub 2013 Nov 17.
4
An appraisal of allergic disorders in India and an urgent call for action.印度过敏性疾病评估及行动的紧急呼吁。
World Allergy Organ J. 2020 Aug 1;13(7):100446. doi: 10.1016/j.waojou.2020.100446. eCollection 2020 Jul.
5
Introduction.引言。
Ann Ital Chir. 2019;90:371-372.
6
Covid-19 pandemic and pediatric healthcare policy in Italy: time for a change.意大利的新冠疫情与儿科医疗政策:变革之时
Pediatr Rep. 2020 Aug 6;12(2):8823. doi: 10.4081/pr.2020.8823.
7
Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.变应性疾病患者的精准医学:气道疾病和特应性皮炎-PRACTALL 欧洲过敏与临床免疫学会和美国过敏、哮喘与免疫学会文件
J Allergy Clin Immunol. 2016 May;137(5):1347-58. doi: 10.1016/j.jaci.2016.03.010.
8
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.临床实践指南:鼻出血(鼻衄)执行摘要。
Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955.
9
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA).中度至重度成人特应性皮炎的诊断与管理:意大利皮肤病与性病学会(SIDeMaST)、意大利医院皮肤科医生协会(ADOI)、意大利过敏、哮喘与临床免疫学学会(SIAAIC)以及意大利变应性、环境与职业皮肤病学会(SIDAPA)的共识
G Ital Dermatol Venereol. 2018 Apr;153(2):133-145. doi: 10.23736/S0392-0488.17.05892-8. Epub 2017 Dec 14.
10
Early life environmental exposure in relation to new onset and remission of allergic diseases in school children: Polish Mother and Child Cohort Study.儿童时期环境暴露与新发和缓解过敏性疾病的关系:波兰母婴队列研究。
Allergy Asthma Proc. 2019 Sep 1;40(5):329-337. doi: 10.2500/aap.2019.40.4237.

引用本文的文献

1
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.生物制剂可减轻严重哮喘患者的心理困扰、焦虑和抑郁,尽管有新冠疫情。
Respir Med. 2022 Aug-Sep;200:106916. doi: 10.1016/j.rmed.2022.106916. Epub 2022 Jun 27.
2
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey.新冠疫情期间的过敏患者——临床实践考量:欧洲变态反应与临床免疫学会调查
Clin Transl Allergy. 2022 Jan 17;12(1):e12097. doi: 10.1002/clt2.12097. eCollection 2022 Jan.
3
Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis.肥大细胞稳定剂对新冠疫苗诱导的过敏反应的潜在预防效果。
Clin Mol Allergy. 2021 Dec 13;19(1):25. doi: 10.1186/s12948-021-00162-9.
4
A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette-Guérin Vaccine Be Effective Against SARS-CoV2?COVID-19疫情期间对意大利医生的一项调查。卡介苗对SARS-CoV2有效吗?
Front Pharmacol. 2021 May 3;12:646570. doi: 10.3389/fphar.2021.646570. eCollection 2021.

本文引用的文献

1
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020).ARIA-EAACI关于哮喘与2019冠状病毒病的声明(2020年6月2日)
Allergy. 2021 Mar;76(3):689-697. doi: 10.1111/all.14471. Epub 2020 Sep 21.
2
Could anti-tubercular vaccination protect against COVID-19 infection?抗结核疫苗能预防新冠病毒感染吗?
Allergy. 2021 Mar;76(3):942-945. doi: 10.1111/all.14443. Epub 2020 Jul 9.
3
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper.COVID-19 大流行:关于组织过敏诊所的实用注意事项——一项 EAACI/ARIA 立场文件。
Allergy. 2021 Mar;76(3):648-676. doi: 10.1111/all.14453.
4
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement.COVID-19 大流行时期变应性疾病患者使用生物制剂的相关考虑:一项 EAACI 立场声明。
Allergy. 2020 Nov;75(11):2764-2774. doi: 10.1111/all.14407.
5
Is asthma protective against COVID-19?哮喘对新型冠状病毒肺炎有保护作用吗?
Allergy. 2021 Mar;76(3):866-868. doi: 10.1111/all.14426. Epub 2020 Jun 17.
6
Considering BCG vaccination to reduce the impact of COVID-19.考虑接种卡介苗以减轻新型冠状病毒肺炎的影响。
Lancet. 2020 May 16;395(10236):1545-1546. doi: 10.1016/S0140-6736(20)31025-4. Epub 2020 Apr 30.
7
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.呼吸道过敏、哮喘与新型冠状病毒受体血管紧张素转换酶2表达的关联。
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3. doi: 10.1016/j.jaci.2020.04.009. Epub 2020 Apr 22.
8
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.B细胞在新冠病毒疾病中可能发挥的作用?来自无丙种球蛋白血症患者的启示。
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4. doi: 10.1016/j.jaci.2020.04.013. Epub 2020 Apr 22.
9
Doubling Time of the COVID-19 Epidemic by Province, China.中国各省份新冠疫情倍增时间。
Emerg Infect Dis. 2020 Aug;26(8):1912-1914. doi: 10.3201/eid2608.200219. Epub 2020 Apr 24.
10
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.应对 COVID-19 大流行期间的变应原免疫治疗:ARIA-EAACI 立场声明。
Allergy. 2020 Jul;75(7):1546-1554. doi: 10.1111/all.14336.